The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia.
 
Kathryn Cappell
No Relationships to Disclose
 
Richard Mark Sherry
No Relationships to Disclose
 
James C. Yang
Research Funding - Kite/Gilead (Inst)
Patents, Royalties, Other Intellectual Property - Royalties on inventions may go to my institution (NCI) which may pass a portion (anonymously) to me.
 
Stephanie L. Goff
No Relationships to Disclose
 
Danielle Vanasse
No Relationships to Disclose
 
Lori McIntyre
No Relationships to Disclose
 
Steven A. Rosenberg
Research Funding - Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); ZIOPHARM Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patents held by NIH
 
James N. Kochenderfer
Research Funding - Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Kite, a Gilead Company and Celegene
Travel, Accommodations, Expenses - Clinical Care Options